Pacer Advisors
NVAX icon

Pacer Advisors’s Novavax NVAX Stock Holding History

Pacer Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33K Buy
+3,486
New +$31.2K ﹤0.01% 2139
2024
Q3 		– Sell
-1,489
Closed -$18.9K – 2648
2024
Q2 		$18.9K Sell
1,489
-6,339
-81% -$63.8K ﹤0.01% 3439
2024
Q1 		$37.4K Buy
+7,828
New +$36.3K ﹤0.01% 3288
2021
Q2 		– Sell
-380
Closed -$69K – 1503
2021
Q1 		$69K Sell
380
-666
-64% -$133K ﹤0.01% 1383
2020
Q4 		$117K Sell
1,046
-1,260
-55% -$134K ﹤0.01% 1340
2020
Q3 		$250K Buy
+2,306
New +$281K 0.01% 1153
2018
Q4 		– Sell
-3,012
Closed -$113K – 886
2018
Q3 		$113K Buy
+3,012
New +$84.8K ﹤0.01% 1078

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Pacer Advisors's NVAX Position: Q2 2026 in Review

Pacer Advisors opened a new position in Novavax (NVAX) in Q2 2026: 3,486 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #2139 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in NVAX as recently as Q2 2024.

Pacer Advisors first reported a position in NVAX in Q3 2018 and has held it in 7 quarters since. The position peaked at $250K in Q3 2020. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Pacer Advisors held 3,486 shares of Novavax worth $33K as of Q2 2026.
  • Novavax was a new Pacer Advisors position in Q2 2026.
  • Novavax made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2139 holding.
  • Pacer Advisors first reported a position in Novavax in Q3 2018 and has held it in 7 quarters since.
  • Pacer Advisors's Novavax position peaked at $250K in Q3 2020.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.